Viewing Study NCT03355794


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-02-21 @ 5:12 PM
Study NCT ID: NCT03355794
Status: COMPLETED
Last Update Posted: 2023-01-13
First Post: 2017-11-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
Sponsor: Children's Hospital Medical Center, Cincinnati
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CONNECT1701_LEE/RAD17T-MD-1604
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View